curcumin has been researched along with sorbitan-monostearate* in 4 studies
4 other study(ies) available for curcumin and sorbitan-monostearate
Article | Year |
---|---|
Surface-functionalized curcumin-loaded polymeric nanocapsules could block apomorphine-induced behavioral changes in rats.
Surface functionalization enhances the properties and characteristics of polymeric nanocapsules (NCs) mainly due to the surface charge, surfactants, and polymer coating type. Curcumin (CUR) is a bioactive compound with several proven pharmacological properties and low bioavailability. This study aimed to develop anionic (poly-ɛ-caprolactone; PCL) and cationic (Eudragit. A two-level, three-factor design (polymer, Span type, and TPGS concentration) was used. The biological effects of CUR-loaded TPGS-coated cationic and anionic NCs were assessed in apomorphine-induced stereotyped behavior in rats.. The type of polymer (anionic or cationic) and Span. The CUR-loaded TPGS-coated NCs proved to be a promising brain delivery system. Topics: Animals; Apomorphine; Behavior, Animal; Curcumin; Dopamine Agonists; Enzyme Inhibitors; Hexoses; Nanocapsules; Plants, Medicinal; Rats; Stereotyped Behavior; Treatment Outcome; Vitamin E | 2022 |
A novel approach to arthritis treatment based on resveratrol and curcumin co-encapsulated in lipid-core nanocapsules: In vivo studies.
Resveratrol and curcumin are two natural polyphenols extensively used due to their remarkable anti-inflammatory activity. The present work presents an inedited study of the in vivo antioedematogenic activity of these polyphenols co-encapsulated in lipid-core nanocapsules on Complete Freund's adjuvant (CFA)-induced arthritis in rats. Lipid-core nanocapsules were prepared by interfacial deposition of preformed polymer. Animals received a single subplantar injection of CFA in the right paw. Fourteen days after arthritis induction, they were treated with resveratrol, curcumin, or both in solution or loaded in lipid-core nanocapsules (1.75 mg/kg/twice daily, i.p.), for 8 days. At the doses used, the polyphenols in solution were not able to decrease paw oedema. However, nanoencapsulation improved the antioedematogenic activity of polyphenols at the same doses. In addition, the treatment with co-encapsulated polyphenols showed the most pronounced effects, where an inhibition of 37-55% was observed between day 16 and 22 after arthritis induction. This treatment minimized most of the histological changes observed, like fibrosis in synovial tissue, cartilage and bone loss. In addition, unlike conventionally arthritis treatment, resveratrol and curcumin co-encapsulated in lipid-core nanocapsules did not alter important hepatic biochemical markers (ALP, AST, and ALT). In conclusion, the strategy of co-encapsulating resveratrol and curcumin in lipid-core nanocapsules improves their efficacy as oedematogenic agents, with no evidence of hepatotoxic effects. This is a promising strategy for the development of new schemes for treatment of chronic inflammation diseases, like arthritis. Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Curcumin; Drug Carriers; Foot Joints; Grape Seed Extract; Hexoses; Injections, Intraperitoneal; Male; Nanocapsules; Polyesters; Polysorbates; Rats, Wistar; Resveratrol; Stilbenes; Treatment Outcome | 2015 |
Skin penetration behavior of lipid-core nanocapsules for simultaneous delivery of resveratrol and curcumin.
Polyphenols, which are secondary plant metabolites, gain increasing research interest due to their therapeutic potential. Among them, resveratrol and curcumin are two agents showing antioxidant, anti-inflammatory, antimicrobial as well as anticarcinogenic effects. In addition to their individual therapeutic effect, increased activity was reported upon co-delivery of the two compounds. However, due to the poor water solubility of resveratrol and curcumin, their clinical application is currently limited. In this context, lipid-core nanocapsules (LNC) composed of an oily core surrounded by a polymeric shell were introduced as drug carrier systems with the potential to overcome this obstacle. Furthermore, the encapsulation of polyphenols into LNC can increase their photostability. As the attributes of the polyphenols make them excellent candidates for skin treatment, the aim of this study was to investigate the effect of co-delivery of resveratrol and curcumin by LNC upon topical application on excised human skin. In contrast to the formulation with one polyphenol, resveratrol penetrated into deeper skin layers when the co-formulation was applied. Based on vibrational spectroscopy analysis, these effects are most likely due to interactions of curcumin and the stratum corneum, facilitating the skin absorption of the co-administered resveratrol. Furthermore, the interaction of LNC with primary human skin cells was analyzed encountering a cellular uptake within 24h potentially leading to intracellular effects of the polyphenols. Thus, the simultaneous delivery of resveratrol and curcumin by LNC provides an intelligent way for immediate and sustained polyphenol delivery for skin disease treatment. Topics: Cell Survival; Cells, Cultured; Curcumin; Drug Carriers; Drug Liberation; Fibroblasts; Grape Seed Extract; Hexoses; Humans; In Vitro Techniques; Nanocapsules; Oils; Polyesters; Polyphenols; Resveratrol; Skin Absorption; Stilbenes | 2015 |
Preparation of curcuminoid niosomes for enhancement of skin permeation.
Curcuminoids (curcumin, desmethoxycurcumin, and bisdesmethoxycurcumin) are major bioactive substances found in turmeric (Curcuma longa L.) extracts and possess antioxidant, anti-inflammatory, antimicrobial and anticancer properties. In this study, curcuminoid niosomes prepared with a series of Span non-ionic surfactants were developed to enhance the skin permeation of curcuminoids. Formulations were evaluated based on aggregation of niosomes, curcuminoid loading, % entrapment efficiency and in vitro permeation of curcuminoids through shed snake skin. Optimal formulations of curcuminoid niosomes including sorbitan monooleate, cholesterol, and Solulan C-24 at a mole ratio of 47.5:47.5:5 were obtained. Up to 11 micromoles of curcuminoids could be loaded in the niosome with a % entrapment efficiency of 83%. About 90% of the niosomes had a diameter of 12.25 +/- 5.00 microm. The niosomes significantly enhanced permeation of curcuminoids compared with a methanolic solution of curcuminoids: 4% of entrapped curcuminoids traversed the shed snake skin, whereas permeation from the methanolic solution was undetectable. The fluxes of curcumin, desmethoxycurcumin, and bisdesmethoxycurcumin were 1.117, 0.263, and 0.057 microg/(cm2h), respectively, consistent with the relative hydrophobicity of curcumin > desmethoxycurcumin > bisdesmethoxycurcumin. In conclusion, our data show that curcuminoids can be successfully formulated as niosomes and that such formulations have improved properties for transdermal delivery. Topics: Animals; Chemistry, Pharmaceutical; Cholesterol; Chromatography, High Pressure Liquid; Curcumin; Hexoses; In Vitro Techniques; Indicators and Reagents; Liposomes; Microscopy, Electron, Scanning; Particle Size; Permeability; Reproducibility of Results; Skin Absorption; Snakes; Surface-Active Agents | 2011 |